Compare BIO-TECHNE Corp (TECH) vs Xylem, Inc. (XYL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Xylem, Inc. — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Xylem, Inc. trades at $120.79 (market cap $28.67B). The key difference: Xylem, Inc. is far larger — about 2.6× BIO-TECHNE Corp's market cap, and Xylem, Inc. pays the higher dividend (1.43%). Which is the better fit depends on your goals.
| TECH | XYL | |
|---|---|---|
Market Cap | $11.16B | $28.67B |
Sector | Health | Industrials |
52-Week High | $72.12 | $152.95 |
52-Week Low | $43.31 | $106.34 |
Enterprise Value | $11.24B | $29.92B |
Dividend Yield | 0.45% | 1.43% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →
